Thu, September 22, 2022

Derek Archila Maintained (ASND) at Buy with Increased Target to $172 on, Sep 22nd, 2022

Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $167 to $172 on, Sep 22nd, 2022.

Derek has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 0 agree with Derek's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Derek


  • Caroline Palomeque of "Berenberg" Initiated at Strong Buy and Held Target at $166 on, Tuesday, August 30th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $168 on, Thursday, August 11th, 2022
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $144 on, Thursday, August 11th, 2022
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Thursday, August 11th, 2022